(Reuters) - Drugmaker AbbVie Inc raised its full-year adjusted profit forecast on Friday, as demand soared for its Botox anti-wrinkle injection in the second quarter following the easing of COVID-19 restrictions. ...
PARIS (Reuters) - French asset manager Amundi reported on Friday 7.2 billion euros ($8.55 billion) in net inflows in the second quarter, saying investors' appetite for more risky assets such as...
By Deena Beasley (Reuters) -Gilead Sciences Inc on Thursday posted a higher-than-expected second-quarter profit, helped by strong demand for its COVID-19 antiviral...
By Alistair Smout and Pushkala Aripaka LONDON (Reuters) - AstraZeneca is exploring options for the future of its...
By Michelle Conlin NEW YORK (Reuters) - Beset by COVID-19 and its fallout, local landlords are offloading their...
By Pushkala Aripaka and Alistair Smout (Reuters) -Second-quarter sales of AstraZeneca's COVID-19 vaccine more than tripled to $894 million from the first...
By Manas Mishra and Carl O'Donnell (Reuters) -Merck & Co reported quarterly revenue on Thursday that topped Wall Street estimates, as sales...
FRANKFURT (Reuters) -Bayer said on Thursday it would book an additional provision of $4.5 billion related to litigation which alleges that its weedkiller Roundup can cause cancer. ...
By Matthias Blamont PARIS (Reuters) -Sanofi raised its 2021 profit forecast on Thursday after its vaccines and star eczema treatment Dupixent helped...
By Manas Mishra and Michael Erman (Reuters) -Pfizer Inc on Wednesday raised its 2021 sales forecast for its COVID-19 vaccine by 29%...